News

News
JNJ Press releases

Johnson & Johnson Innovation Announces Collaboration with National Academy of Medicine to Help People Live Longer, Healthier Lives

Read full story
Partner news

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Read full story
Other news

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

Read full story
JNJ Press releases

Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020

Read full story
Partner news

BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-335140

Read full story
Other news

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Read full story
Partner news

AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics

Read full story
Partner news

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

Read full story
In the media

J&J’s Global Head of Communication - External Innovation, on how partnerships are fuelling the company’s vision for a World Without Disease.

Read full story
Partner news

Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

Read full story
Partner news

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Read full story
Partner news

New strategic partners join £9.5 million dementia drug discovery collaboration

Read full story
In the media

Reimagining the future of healthcare with William Hait

Read full story
In the media

GCV Rising Stars Awards 2019: #4 Marian Nakada

Read full story
JNJ Press releases

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases

Read full story